A retrospective, single-centre, observational study to evaluate safety and efficacy of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
Phase of Trial: Phase IV
Latest Information Update: 22 Aug 2017
At a glance
- Drugs Dabigatran etexilate (Primary) ; Acenocoumarol
- Indications Atrial fibrillation
- Focus Adverse reactions; Therapeutic Use
- 22 Aug 2017 New trial record